Prenatal androgen excess programs metabolic derangements in pubertal female rats

Journal of Endocrinology

Volumn 217, Issue 1, 2013, Pages 119-129

  Yan, Xiaonan ^a   Dai, Xiaonan ^a   Wang, Jing ^a   Zhao, Nannan ^a   Cui, Yugui ^a   Liu, Jiayin ^a  

^a NANJING MEDICAL UNIVERSITY   (China)

Author keywords

Fetal origin of adult disease; Insulin resistance; Insulin signaling; Polycystic ovary syndrome; Prenatal androgen exposure

Indexed keywords

ANDROGEN; ANDROSTANOLONE; GLUCOSE; INSULIN; INSULIN RECEPTOR SUBSTRATE 1; INSULIN RECEPTOR SUBSTRATE 2; LEPTIN; PROTEIN KINASE B; AKT1 PROTEIN, RAT; INSULIN RECEPTOR SUBSTRATE;

ADIPOSE TISSUE; ADOLESCENT; ANDROGEN THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FEMALE; FOLLICLE CYST; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HOMEOSTASIS; HORMONE BLOOD LEVEL; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INSULIN TOLERANCE TEST; INTRAPERITONEAL GLUCOSE TOLERANCE TEST; INTRAPERITONEAL INSULIN TOLERANCE TEST; LIVER; LIVER LEVEL; METABOLIC DISORDER; MORPHOLOGY; MUSCLE LEVEL; NEWBORN; NONHUMAN; OVARY FOLLICLE; OVARY FOLLICLE ATRESIA; OVARY POLYCYSTIC DISEASE; PATHOGENESIS; PERINATAL PERIOD; PREGNANCY; PRENATAL DEVELOPMENT; PRENATAL EXPOSURE; PRENATAL PERIOD; PRIORITY JOURNAL; PROGENY; PUBERTY; RAT; SKELETAL MUSCLE; ANIMAL; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; FETUS DEVELOPMENT; GLUCOSE INTOLERANCE; METABOLISM; OVARY CYST; PATHOLOGY; PHOSPHORYLATION; PROTEIN PROCESSING; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT;

ANDROGENS; ANIMALS; DIHYDROTESTOSTERONE; FEMALE; FETAL DEVELOPMENT; FOLLICULAR ATRESIA; GLUCOSE INTOLERANCE; INSULIN RECEPTOR SUBSTRATE PROTEINS; INSULIN RESISTANCE; LIVER; MUSCLE, SKELETAL; OVARIAN CYSTS; OVARIAN FOLLICLE; PHOSPHORYLATION; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PRENATAL EXPOSURE DELAYED EFFECTS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION;

MLCS; MLOWN;

EID: 84877135079     PISSN: 00220795     EISSN: 14796805     Source Type: Journal    
DOI: 10.1530/JOE-12-0577     Document Type: Article

References (46)

1. Abbott DH, Dumesic DA & Franks S 2002 Developmental origin of polycystic ovary syndrome - a hypothesis. Journal of Endocrinology 174 1-5. (doi:10.1677/joe.0.1740001)
2. Abbott DH, Barnett DK, Levine JE, Padmanabhan V, Dumesic DA, Jacoris S & Tarantal AF 2008a Endocrine antecedents of polycystic ovary syndrome in fetal and infant prenatally androgenized female rhesus monkeys. Biology of Reproduction 79 154-163. (doi:10.1095/biolreprod. 108.067702)
3. Abbott DH, Zhou R, Bird IM, Dumesic DA & Conley AJ 2008b Fetal programming of adrenal androgen excess: lessons from a nonhuman primate model of polycystic ovary syndrome. Endocrine Development 13 145-158. (doi:10.1159/000134831)
4. Abbott DH, Tarantal AF & Dumesic DA 2009 Fetal, infant, adolescent and adult phenotypes of polycystic ovary syndrome in prenatally androgenized female rhesus monkeys. American Journal of Primatology 71 776-784. (doi:10.1002/ajp.20679)
5. Amalfi S, Velez LM, Heber MF, Vighi S, Ferreira SR, Orozco AV, Pignataro O & Motta AB 2012 Prenatal hyperandrogenization induces metabolic and endocrine alterations which depend on the levels of testosterone exposure. PLoS ONE 7 e37658. (doi:10.1371/journal.pone.0037658)
6. Arslanian SA, Lewy VD & Danadian K 2001 Glucose intolerance in obese adolescents with polycystic ovary syndrome: roles of insulin resistance and b-cell dysfunction and risk of cardiovascular disease. Journal of Clinical Endocrinology and Metabolism 86 66-71. (doi:10.1210/jc.86.1.66)
7. Azziz R, Carmina E, Dewailly D, Diamanti-Kandarakis E, Escobar-Morreale HF, Futterweit W, Janssen OE, Legro RS, Norman RJ, Taylor AE et al. 2009 The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. Fertility and Sterility 91 456-488. (doi:10.1016/j.fertnstert.2008.06.035)
8. Bremer AA 2010 Polycystic ovary syndrome in the pediatric population. Metabolic Syndrome and Related Disorders 8 375-394. (doi:10.1089/met.2010.0039)
9. Bridger T, MacDonald S, Baltzer F & Rodd C 2006 Randomized placebocontrolled trial of metformin for adolescents with polycystic ovary syndrome. Archives of Pediatrics & Adolescent Medicine 160 241-246. (doi:10.1001/archpedi.160.3.241)
10. Broder-Fingert S, Shah B, Kessler M, Pawelczak M & David R 2009 Evaluation of adolescents for polycystic ovary syndrome in an urban population. Journal of Clinical Research in Pediatric Endocrinology 1 188-193. (doi:10.4008/jcrpe.v1i4.50)
11. Corbould A 2008 Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes? Panminerva Medica 50 279-294.
12. Corbould A & Dunaif A 2007 The adipose cell lineage is not intrinsically insulin resistant in polycystic ovary syndrome. Metabolism: Clinical and Experimental 56 716-722. (doi:10.1016/j.metabol.2006.12.021)
13. Corbould A, Kim YB, Youngren JF, Pender C, Kahn BB, Lee A & Dunaif A 2005 Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling. American Journal of Physiology. Endocrinology and Metabolism 288 E1047-E1054. (doi:10.1152/ajpendo.00361.2004)
14. Corbould A, Zhao H, Mirzoeva S, Aird F & Dunaif A 2006 Enhanced mitogenic signaling in skeletal muscle of women with polycystic ovary syndrome. Diabetes 55 751-759. (doi:10.2337/diabetes.55.03.06. db05-0453)
15. Coviello AD, Legro RS & Dunaif A 2006 Adolescent girls with polycystic ovary syndrome have an increased risk of the metabolic syndrome associated with increasing androgen levels independent of obesity and insulin resistance. Journal of Clinical Endocrinology and Metabolism 91 492-497. (doi:10.1210/jc.2005-1666)
16. Demissie M, Lazic M, Foecking EM, Aird F, Dunaif A & Levine JE 2008 Transient prenatal androgen exposure producesmetabolic syndrome in adult female rats. American Journal of Physiology. Endocrinology and Metabolism 295 E262-E268. (doi:10.1152/ajpendo.90208.2008)
17. Diamanti-Kandarakis E & Dunaif A 2012 Insulin resistance and the polycystic ovary syndrome revisited: an update on mechanisms and implications. Endocrine Reviews 33 981-1030. (doi:10.1210/er.2011-1034)
18. Dunaif A, Wu X, Lee A & Diamanti-Kandarakis E 2001 Defects in insulin receptor signaling in vivo in the polycystic ovary syndrome (PCOS). American Journal of Physiology. Endocrinology and Metabolism 281 E392-E399.
19. Foecking EM, Szabo M, Schwartz NB & Levine JE 2005 Neuroendocrine consequences of prenatal androgen exposure in the female rat: absence of luteinizing hormone surges, suppression of progesterone receptor gene expression, and acceleration of the gonadotropin-releasing hormone pulse generator. Biology of Reproduction 72 1475-1483. (doi:10.1095/biolreprod.105.039800)
20. Forsdike RA, Hardy K, Bull L, Stark J, Webber LJ, Stubbs S, Robinson JE & Franks S 2007 Disordered follicle development in ovaries of prenatally androgenized ewes. Journal of Endocrinology 192 421-428. (doi:10.1677/joe.1.07097)
21. Franks S 2012 Animal models and the developmental origins of polycystic ovary syndrome: increasing evidence for the role of androgens in programming reproductive and metabolic dysfunction. Endocrinology 153 2536-2538. (doi:10.1210/en.2012-1366)
22. Franks S, McCarthy MI & Hardy K 2006 Development of polycystic ovary syndrome: involvement of genetic and environmental factors. International Journal of Andrology 29 278-284. (doi:10.1111/j.1365-2605.2005.00623.x)
23. Heber MF, Ferreira SR, Velez LM & Motta AB 2012 Prenatal hyperandrogenism and lipid profile during different age stages: an experimental study. Fertility and Sterility 99 551-557. (doi:10.1016/j.fertnstert. 2012.10.017)
24. Hojlund K, Glintborg D, Andersen NR, Birk JB, Treebak JT, Frosig C, Beck-Nielsen H & Wojtaszewski JFP 2008 Impaired insulin-stimulated phosphorylation of Akt and AS160 in skeletal muscle of women with polycystic ovary syndrome is reversed by pioglitazone treatment. Diabetes 57 357-366. (doi:10.2337/db07-0706)
25. Huang J, Ni R, Chen X, Huang L, Mo Y & Yang D 2010 Metabolic abnormalities in adolescents with polycystic ovary syndrome in south China. Reproductive Biology and Endocrinology 8 142. (doi:10.1186/1477- 7827-8-142)
26. Kahsar-Miller MD, Nixon C, Boots LR, Go RC & Azziz R 2001 Prevalence of polycystic ovary syndrome (PCOS) in first-degree relatives of patients with PCOS. Fertility and Sterility 75 53-58. (doi:10.1016/S0015- 0282(00)01662-9)
27. Leonie E, van Houten AF, Kramer P, McLuskey A, Karels B, Themmen APN & Visser JA 2012 Reproductive and metabolic phenotype of a mouse model of PCOS. Endocrinology 153 2861-2869. (doi:10.1210/en.2011-1754)
28. Lewy VD, Danadian K, Witchel SF & Arslanian S 2001 Early metabolic abnormalities in adolescent girls with polycystic ovarian syndrome. Journal of Pediatrics 138 38-44. (doi:10.1067/mpd.2001.109603)
29. Manneras L, Cajander S, Holmang A, Seleskovic Z, Lystig T, Lonn M & Stener-Victorin E 2007 A new rat model exhibiting both ovarian and metabolic characteristics of polycystic ovary syndrome. Endocrinology 148 3781-3791. (doi:10.1210/en.2007-0168)
30. Matsumoto AM & Bremner WJ 2004 Serum testosterone assays - accuracy matters. Journal of Clinical Endocrinology and Metabolism 89 520-524. (doi:10.1210/jc.2003-032175)
31. Nada SE, Thompson RC & Padmanabhan V 2010 Developmental programming: differential effects of prenatal testosterone excess on insulin target tissues. Endocrinology 151 5165-5173. (doi:10.1210/en.2010-0666)
32. Padmanabhan V, Veiga-Lopez A, Abbott DH, Recabarren SE & Herkimer C 2010 Developmental programming: impact of prenatal testosterone excess and postnatal weight gain on insulin sensitivity index and transfer of traits to offspring of overweight females. Endocrinology 151 595-605. (doi:10.1210/en.2009-1015)
33. Palmert MR, Gordon CM, Kartashov AI, Legro RS, Emans SJ & Dunaif A 2002 Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 87 1017-1023. (doi:10.1210/jc.87.3.1017)
34. Rajkhowa M, Brett S, Cuthbertson DJ, Lipina C, Ruiz-Alcaraz AJ, Thomas GE, Logie L, Petrie JR & Sutherland C 2009 Insulin resistance in polycystic ovary syndrome is associated with defective regulation of ERK1/2 by insulin in skeletal muscle in vivo. Biochemical Journal 418 665-671. (doi:10.1042/BJ20082176)
35. Roland AV, Nunemaker CS, Keller SR & Moenter SM 2010 Prenatal androgen exposure programs metabolic dysfunction in female mice. Journal of Endocrinology 207 213-223. (doi:10.1677/JOE-10-0217)
36. Rosenfield RL 2007 Identifying children at risk for polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 92 787-796. (doi:10.1210/jc.2006-2012)
37. Rosner W, Auchus RJ, Azziz R, Sluss PM & Raff H 2007 Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement. Journal of Clinical Endocrinology and Metabolism 92 405-413. (doi:10.1210/jc.2006-1864)
38. Sahu A 2004 Minireview: a hypothalamic role in energy balance with special emphasis on leptin. Endocrinology 145 2613-2620. (doi:10.1210/en.2004-0032)
39. Shi D, Dyck MK, Uwiera RRE, Russell JC, Proctor SD & Vine DF 2009 A unique rodent model of cardiometabolic risk associated with the metabolic syndrome and polycystic ovary syndrome. Endocrinology 150 4425-4436. (doi:10.1210/en.2008-1612)
40. Silfen ME, Denburg MR, Manibo AM, Lobo RA, Jaffe R, Ferin M, Levine LS & Oberfield SE 2003 Early endocrine, metabolic, and sonographic characteristics of polycystic ovary syndrome (PCOS): comparison between nonobese and obese adolescents. Journal of Clinical Endocrinology and Metabolism 88 4682-4688. (doi:10.1210/jc.2003-030617)
41. Sir-Petermann T, Maliqueo M, Codner E, Echiburu B, Crisosto N, Perez V, Perez-Bravo F & Cassorla F 2007 Early metabolic derangements in daughters of women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 92 4637-4642. (doi:10.1210/jc.2007-1036)
42. Sir-Petermann T, Codner E, Perez V, Echiburu B, Maliqueo M, Ladron de Guevara A, Preisler J, Crisosto N, Sanchez F, Cassorla F et al. 2009 Metabolic and reproductive features before and during puberty in daughters of women with polycystic ovary syndrome. Journal of Clinical Endocrinology and Metabolism 94 1923-1930. (doi:10.1210/jc.2008-2836)
43. Sullivan SD & Moenter SM 2004 Prenatal androgens alter GABAergic drive to gonadotropin-releasing hormone neurons: implications for a common fertility disorder. PNAS 101 7129-7134. (doi:10.1073/pnas.0308058101)
44. Teede HJ, Hutchison S, Zoungas S & Meyer C 2006 Insulin resistance, the metabolic syndrome, diabetes, and cardiovascular disease risk in women with PCOS. Endocrine 30 45-53. (doi:10.1385/ENDO:30:1:45)
45. Tyndall V, Broyde M, Sharpe R, Welsh M, Drake AJ & McNeilly AS 2012 Effect of androgen treatment during foetal and/or neonatal life on ovarian function in prepubertal and adult rats. Reproduction 143 21-33. (doi:10.1530/REP-11-0239)
46. Xita N & Tsatsoulis A 2006 Review: fetal programming of polycystic ovary syndrome by androgen excess: evidence from experimental, clinical, and genetic association studies. Journal of Clinical Endocrinology and Metabolism 91 1660-1666. (doi:10.1210/jc.2005-2757)